Dr. Mary Lynne Hedley is a scientist, entrepreneur, biotechnology executive and corporate director with 25 years of experience working in the life science industry. She also currently serves on the board of directors of biopharmaceutical company, Millendo Therapeutics, Inc.
She most recently served as president and chief operating officer at TESARO, an oncology-focused pharmaceutical company she co-founded in 2010 and that was acquired by GSK in 2019. Prior to that she served as executive vice president of operations and chief scientific officer at biotechnology company, Abraxis BioScience, Inc. She was also executive vice president of Eisai Corporation of North America following the company’s acquisition of MGI PHARMA, Inc. Before that she served in various positions at MGI PHARMA, Inc., most recently as executive vice president and chief scientific officer. Dr. Hedley also co-founded and served as the president and CEO of ZYCOS, Inc., a biotechnology company that was acquired by MGI PHARMA, Inc. in 2004.
She has previously served on the board of directors of TESARO, Inc., bluebird bio, and Receptos, Inc., which was acquired by Celgene Corp. in August 2015.
Dr. Hedley received a bachelor of science in microbiology from Purdue University and a Ph.D. in Immunology from the University of Texas, Southwestern Medical Center.
What is Mary Lynne Hedley's net worth?
The estimated net worth of Mary Lynne Hedley is at least $878,327.10 as of December 27th, 2023. Dr. Hedley owns 4,170 shares of Veeva Systems stock worth more than $878,327 as of November 21st. This net worth estimate does not reflect any other investments that Dr. Hedley may own. Learn More about Mary Lynne Hedley's net worth.
How do I contact Mary Lynne Hedley?
Has Mary Lynne Hedley been buying or selling shares of Veeva Systems?
Mary Lynne Hedley has not been actively trading shares of Veeva Systems over the course of the past ninety days. Most recently, Mary Lynne Hedley sold 41 shares of the business's stock in a transaction on Wednesday, December 27th. The shares were sold at an average price of $190.96, for a transaction totalling $7,829.36. Following the completion of the sale, the director now directly owns 4,170 shares of the company's stock, valued at $796,303.20. Learn More on Mary Lynne Hedley's trading history.
Who are Veeva Systems' active insiders?
Veeva Systems' insider roster includes Timothy Barabe (Director), Brent Bowman (CFO), Timothy Cabral (CFO), Paul Chamberlain (Director), Ronald Codd (Director), Jonathan Faddis (SVP), Peter Gassner (Founder, CEO, Director), Mary Hedley (Director), Frederic Lequient (SVP), Alan Mateo (EVP), Michele O'connor (CAO), Thomas Schwenger (COO), Paul Sekhri (Director), Matthew Wallach (President), and Eleni Zuppas (CMO). Learn More on Veeva Systems' active insiders.
Are insiders buying or selling shares of Veeva Systems?
In the last year, insiders at the technology company sold shares 16 times. They sold a total of 81,287 shares worth more than $15,843,847.50. The most recent insider tranaction occured on November, 8th when insider Thomas D Schwenger sold 1,126 shares worth more than $270,251.26. Insiders at Veeva Systems own 10.5% of the company.
Learn More about insider trades at Veeva Systems. Information on this page was last updated on 11/8/2024.